.png)
Agenzia Italiana del Farmaco
FAQ
Agenzia Italiana del Farmaco
Aifa toggle bar Search
-
The Agency
- The Agency
- Mission and values
- Organisation
- Technical and advisory committees
- Support and Coordination Secretariats and Advisory Committees
- International Collaborations
- Legislation
- Forms
- Competition notices
- Resolutions
- Tenders and contracts
- Quality assurance
- Guarantee Committee
- Atti di notifica
- Open AIFA
- Contacts
- Certified email
-
COVID-19 Emergency
- COVID-19 Emergency
- Communications about COVID-19
- COVID-19 Vaccines
- Medicines usable for treatment of COVID-19 disease
- Use of monoclonal antibodies for COVID-19
- Use of antivirals for COVID-19
- Monitoring of medicinal products used during the COVID-19 epidemic
- Recommendations on use of medicines in the population exposed to the virus
- Clinical Trials - COVID-19
- Compassionate Use Programs - COVID-19
-
Access to medicinal products
- Access to medicinal products
- Early access and off-label use
- Authorisation of medicinal products
- Shortages and unavailability
- Antibiotic medicinal products
- Biological medicinal products
- Vaccines
- Blood derivatives
- Generic medicinal products
- Biosimilar medicinal products
- Orphan medicinal products
- Advanced therapies
- Homeopathic medicinal products
- Allergens
-
Safety of medicinal products
- Safety of medicinal products
- Pharmacovigilance
- National Pharmacovigilance Network
- Adverse Reactions to medicinal products
- Persons in charge of Pharmacovigilance
- The RAM System
- European Eudravigilance System
- Regional pharmacovigilance funds
- Pharmacovigilance signals
- PSURs (Periodic safety update reports)
- Risk management measures
- Medicinal products subject to additional monitoring
- Quality and Inspections
- Research and Clinical trials
- Pricing and reimbursement
- Consumption and pharmaceutical expenditure
- Innovation and planning
-
Information and communication
- Information and communication
- FarmaciLine
- Medical and scientific information
- FAQ
- Publications
- ABC della Ricerca Clinica
- Public consultations
- Documents shared with scientific communities
- World news
- Communication campaigns
- Seminari scientifici
- Press releases
- Presentations and speeches
- Calendario eventi
- Archive
- AIFA data
- Companies Section
-
Open governance
- Open governance
- Disposizioni Generali
- Organizzazione
- Consulenti e collaboratori
- Personale
- Bandi di Concorso
- Performance
- Enti controllati
- Attività e procedimenti
- Provvedimenti
- Bandi di gara e contratti
- Sovvenzioni, contributi, sussidi, vantaggi economici
- Bilanci
- Beni immobili e gestione patrimonio
- Controlli e rilievi sull'Amministrazione
- Servizi Erogati
- Pagamenti dell'Amministrazione
- Opere pubbliche
- Pianificazione e governo del territorio
- Informazioni ambientali
- Interventi straordinari di emergenza
- Altri Contenuti
Agenzia Italiana del Farmaco
Cookie Bar
Footer
Contacts
Via del Tritone, 181 00187 Roma
VAT number: 08703841000
Tax code: 97345810580
IPA AIFA code: aifa_rm
IPA UCB code: UFE1TR